Neuromelanin of the Human Substantia Nigra: An Update
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Dopaminergic neurons of the substantia nigra selectively degenerate over the course of Parkinson's disease. These neurons are also the most heavily pigmented cells of the brain, accumulating the dark pigment neuromelanin over a lifetime. The massive presence of neuromelanin in these brain areas has long been suspected as a key factor involved in the selective vulnerability of neurons. The high concentration of neuromelanin in substantia nigra neurons seems to be linked to the presence of considerable amounts of cytosolic dopamine that have not been sequestered into synaptic vesicles. Over the past few years, studies have uncovered a dual nature of neuromelanin. Intraneuronal neuromelanin can be a protective factor, shielding the cells from toxic effects of redox active metals, toxins, and excess of cytosolic catecholamines. In contrast, neuromelanin released by dying neurons can contribute to the activation of neuroglia triggering the neuroinflammation that characterizes Parkinson's disease. This article reviews recent studies on the molecular aspects of neuromelanin of the human substantia nigra.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Locus coeruleus neurons contain norepinephrine-derived neuromelanin (227, 228); the dorsal motor nucleus of vagus contains neuromelanin that may be dopaminergic (202); and the raphe nuclei contain neuromelanin derived from their neurotransmitter, serotonin.”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [227]
Citations
Cites
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
The physical and chemical properties of eumelanin
Meredith, P., & Sarna, T. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00345.x · Cited by 1,033
Increased nigral iron content in postmortem parkinsonian brain
Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963
Kim, W.-G., Mohney, R. P., Wilson, B., Jeohn, G.-H., Liu, B., & Hong, J.-S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 878
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 752 · cited 1×
“Under iron overload conditions, as may occur in PD (Dexter et al. 1987, 1989; Earle 1968; Sofic et al. 1988), the high affinity sites of NM could be saturated, and iron might also bind to the low affinity sites.”
BackgroundAging and Extrapyramidal Function
McGeer, P. L., McGeer, E. G., & Suzuki, J. S. (1977) · Archives of Neurology · doi:10.1001/archneur.1977.00500130053010 · Cited by 647
Gibb, W. R., & Lees, A. J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.5.388 · Cited by 574
Chemistry of Mixed Melanogenesis—Pivotal Roles of Dopaquinone†
Ito, S., & Wakamatsu, K. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00238.x · Cited by 503
Sasaki, M., Shibata, E., Tohyama, K., Takahashi, J., Otsuka, K., Tsuchiya, K., Takahashi, S., Ehara, S., Terayama, Y., & Sakai, A. (2006) · Neuroreport · doi:10.1097/01.wnr.0000227984.84927.a7 · Cited by 496
Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495
Self-citationStructures for amyloid fibrils
Makin, O. S., & Serpell, L. C. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.05025.x · Cited by 461
Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
Banati, R. B., Daniel, S. E., & Blunt, S. B. (1998) · Movement Disorders · doi:10.1002/mds.870130205 · Cited by 431 · cited 1×
“A slower degradation activity could mean that NM lasts longer in the tissue, sustaining microglial activation, a condition commonly observed in the PD brain (Banati et al. 1998; Langston et al. 1999; McGeer et al. 1988).”
BackgroundGood, P. F., Olanow, C. W., & Perl, D. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)91334-b · Cited by 427
(1999) · PubMed · Cited by 425
Pakkenberg, B., Moller, A., Gundersen, H. J., Mouritzen Dam, A., & Pakkenberg, H. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.1.30 · Cited by 407
Sulzer, D., Bogulavsky, J., Larsen, K. E., Behr, G., Karatekin, E., Kleinman, M. H., Turro, N., Krantz, D., Edwards, R. H., Greene, L. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.11869 · Cited by 407 · cited 5×
“The pigment is confined within cytoplasmatic organelles that are surrounded by a double membrane, suggesting an autophagic origin (Sulzer et al. 2000).”
BackgroundInfluentialSelf-citationZecca, L., Gallorini, M., Schünemann, V., Trautwein, A. X., Gerlach, M., Riederer, P., Vezzoni, P., & Tampellini, D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00186.x · Cited by 401
Self-citationEnzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase
Hastings, T. G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020919.x · Cited by 359 · cited 1×
“Enzymatic oxidation of DA could also occur via prostaglandin H synthase or xanthine oxidase that leads to the formation of dopaminoquinone (Foppoli et al. 1997; Hastings 1995; Mattammal et al. 1995).”
BackgroundAdvanced Chemical Methods in Melanin Determination
Wakamatsu, K., & Ito, S. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.02017.x · Cited by 350
DUFFY, P. E., & TENNYSON, V. M. (1965) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-196507000-00003 · Cited by 342
Wilms, H., Rosenstiel, P., Sievers, J., Deuschl, G., Zecca, L., & Lucius, R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0314fje · Cited by 337 · cited 1×
“In vitro experiments have shown that human NM added to microglia cultures is able to induce chemotaxis: microglia cells reach toward NM granules, actively phagocytose NM, and release in response neurotoxic mediators such as tumor-necrosis factor a, interleukin 6, and nitric oxide (Wilms et al. 2003), as well as reacti…”
BackgroundSelf-citationIron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis
Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08362.x · Cited by 313
Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to Neuromelanin
D'Amato, R. J., Lipman, Z. P., & Snyder, S. H. (1986) · Science · doi:10.1126/science.3080808 · Cited by 296 · cited 2×
“1988) and 1-methyl-4-phenylpyridinium ion, the toxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (D’Amato et al. 1986).”
BackgroundTHE ROLE OF VESICULAR TRANSPORT PROTEINS IN SYNAPTIC TRANSMISSION AND NEURAL DEGENERATION
Liu, Y., & Edwards, R. H. (1997) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.20.1.125 · Cited by 296
Youdim, M. B. H., Ben-Shachar, D., & Riederer, P. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb01782.x · Cited by 292
Paramagnetic metal scavenging by melanin: MR imaging.
Enochs, W. S., Petherick, P., Bogdanova, A., Mohr, U., & Weissleder, R. (1997) · Radiology · doi:10.1148/radiology.204.2.9240529 · Cited by 290 · cited 1×
“NM and melanins show paramagnetic T1-shortening properties in magnetic resonance imaging (Enochs et al. 1997).”
BackgroundInteraction Between Chemicals and Melanin
LARSSON, B. S. (1993) · Pigment Cell Research · doi:10.1111/j.1600-0749.1993.tb00591.x · Cited by 287 · cited 1×
“Additional dopaminergic drugs are also sequestered by NM, such as chlorpromazine, haloperidol, and imipramine (Larsson 1993; Salazar et al. 1978).”
BackgroundZecca, L., Fariello, R., Riederer, P., Sulzer, D., Gatti, A., & Tampellini, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03269-0 · Cited by 285
Self-citationIntraneuronal dopamine-quinone synthesis: a review
Sulzer, D., & Zecca, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033289 · Cited by 284
Self-citationZhang, W., Phillips, K., Wielgus, A. R., Liu, J., Albertini, A., Zucca, F. A., Faust, R., Qian, S. Y., Miller, D. S., Chignell, C. F., et al. (2011) · Neurotoxicity Research · doi:10.1007/s12640-009-9140-z · Cited by 257
Self-citationParkinson's disease : diagnosis and clinical management
Factor, S. A., & Weiner, W. J. (2002) · Cited by 254
Zecca, L., Bellei, C., Costi, P., Albertini, A., Monzani, E., Casella, L., Gallorini, M., Bergamaschi, L., Moscatelli, A., Turro, N. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808768105 · Cited by 240
Self-citationZecca, L., Casella, L., Albertini, A., Bellei, C., Zucca, F. A., Engelen, M., Zadlo, A., Szewczyk, G., Zareba, M., & Sarna, T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05541.x · Cited by 233
Self-citationFaucheux, B. A., Martin, M., Beaumont, C., Hauw, J., Agid, Y., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01923.x · Cited by 229
Kastner, A., Hirsch, E. C., Lejeune, O., Javoy‐Agid, F., Rascol, O., & Agid, Y. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08350.x · Cited by 228
Earle, K. M. (1968) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196801000-00001 · Cited by 227
On the origin and significance of neuromelanin.
Dg, G. (1979) · PubMed · Cited by 223
Possible role of neuromelanin in the pathogenesis of Parkinson's disease
MANN, D., & YATES, P. (1983) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(83)90074-x · Cited by 211
Zecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0361-7 · Cited by 205
Self-citationTyrosine mRNA is expressed in human substantia nigra
Xu, Y., Stokes, A. H., Freeman, W. M., Kumer, S. C., Vogt, B. A., & Vrana, K. E. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00308-7 · Cited by 205 · cited 1×
“small quantities of mRNA coding for tyrosinase in human SN (Greggio et al. 2005; Xu et al. 1997), but no protein”
BackgroundInteraction of neuromelanin and iron in substantia nigra and other areas of human brain
Zecca, L., Shima, T., Stroppolo, A., Goj, C., Battiston, G. A., Gerbasi, R., Sarna, T., & Swartz, H. M. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00047-4 · Cited by 196
Self-citationSulzer, D., Mosharov, E., Talloczy, Z., Zucca, F. A., Simon, J. D., & Zecca, L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05385.x · Cited by 191
Self-citationT1‐Weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's disease
Schwarz, S. T., Rittman, T., Gontu, V., Morgan, P. S., Bajaj, N., & Auer, D. P. (2011) · Movement Disorders · doi:10.1002/mds.23722 · Cited by 185
Iron-binding characteristics of neuromelanin of the human substantia nigra
Double, K. L., Gerlach, M., Schünemann, V., Trautwein, A. X., Zecca, L., Gallorini, M., Youdim, M. B. H., Riederer, P., & Ben-Shachar, D. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00293-4 · Cited by 181
Self-citationA brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker
Bogerts, B. (1981) · Journal of Comparative Neurology · doi:10.1002/cne.901970106 · Cited by 177 · cited 1×
“In humans, NM is mostly evident in the catecholaminergic nuclei of the human brainstem, SN, and locus coeruleus (Duffy and Tennyson 1965; Fenichel and Bazelon 1968; Foley and Baxter 1958; Graham 1979), but NM-containing neurons are ubiquitous in the brain having been described in several areas including medulla oblong…”
BackgroundVenkateshappa, C., Harish, G., Mythri, R. B., Mahadevan, A., Srinivas Bharath, M. M., & Shankar, S. K. (2012) · Neurochemical Research · doi:10.1007/s11064-011-0619-7 · Cited by 177
The structure of neuromelanin as studied by chemical degradative methods
Wakamatsu, K., Fujikawa, K., Zucca, F. A., Zecca, L., & Ito, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01917.x · Cited by 172
Self-citationOhtsuka, C., Sasaki, M., Konno, K., Koide, M., Kato, K., Takahashi, J., Takahashi, S., Kudo, K., Yamashita, F., & Terayama, Y. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.012 · Cited by 171
Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain
Zecca, L., Pietra, R., Goj, C., Mecacci, C., Radice, D., & Sabbioni, E. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031097.x · Cited by 163
Self-citationWhole-Body Lifetime Occupational Lead Exposure and Risk of Parkinson’s Disease
Coon, S., Stark, A., Peterson, E., Gloi, A., Kortsha, G., Pounds, J., Chettle, D., & Gorell, J. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9102 · Cited by 161 · cited 1×
“associated to occupational exposure to lead (Coon et al. 2006).”
Bush, W. D., Garguilo, J., Zucca, F. A., Albertini, A., Zecca, L., Edwards, G. S., Nemanich, R. J., & Simon, J. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604010103 · Cited by 159 · cited 4×
“Moreover, degradation of NM may also result in exposure of its pheomelanic core which has an oxidation potential thermodynamically favorable for generating oxidative stress (Bush et al. 2006).”
BackgroundInfluentialSelf-citationPreservation of midbrain catecholaminergic neurons in very old human subjects
Kubis, N., Faucheux, B. A., Ransmayr, G., Damier, P., Duyckaerts, C., Henin, D., Forette, B., Le Charpentier, Y., Hauw, J.-J., Agid, Y., et al. (2000) · Brain · doi:10.1093/brain/123.2.366 · Cited by 157 · cited 1×
“variations in the number of pigmented neurons (Gibb and Lees 1991; Kubis et al. 2000; Muthane et al. 1998; Pakkenberg et al. 1991).”
BackgroundFornstedt, B., Rosengren, E., & Carlsson, A. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90242-x · Cited by 156
Gibb, W. R. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)90719-p · Cited by 152 · cited 1×
“Other studies reported that lightly pigmented neurons are more vulnerable than heavily pigmented ones in PD patients (Gibb Neurotox Res (2014) 25:13–23 17”
BackgroundProstaglandin H Synthetase‐Mediated Metabolism of Dopamine: Implication for Parkinson's Disease
Mattammal, M. B., Strong, R., Lakshmi, V. M., Chung, H. D., & Stephenson, A. H. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041645.x · Cited by 151 · cited 1×
“Enzymatic oxidation of DA could also occur via prostaglandin H synthase or xanthine oxidase that leads to the formation of dopaminoquinone (Foppoli et al. 1997; Hastings 1995; Mattammal et al. 1995).”
BackgroundAgeing of substantia nigra in humans: cell loss may be compensated by hypertrophy
Cabello, C. R., Thune, J. J., Pakkenberg, H., & Pakkenberg, B. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00393.x · Cited by 150 · cited 1×
“Assessments of the number of neurons containing NM, mostly in the SN pars compacta and in some cases in locus coeruleus, based only on histologic or indirect enzymatic determinations report either an age-dependent loss (Cabello et al. 2002; Fearnley 16 Neurotox Res (2014) 25:13–23”
BackgroundNeuromelanin and Parkinson's disease.
MARSDEN, C. D. (1983) · PubMed · Cited by 144
The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems
Zaręba, M., Bober, A., Korytowski, W., Zecca, L., & Sarna, T. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00058-c · Cited by 140
Self-citationZucca, F. A., Bellei, C., Giannelli, S. G., Terreni, M., Gallorini, M., Rizzio, E., Pezzoli, G., Albertini, A., & Zecca, L. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0453-2 · Cited by 138
Self-citationShima, T., Sarna, T., Swartz, H. M., Stroppolo, A., Gerbasi, R., & Zecca, L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00623-5 · Cited by 135
Self-citationUnbiased morphometrical measurements show loss of pigmented nigral neurones with ageing
Ma, Röytt, Collan, & Rinne (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00202.x · Cited by 132
On the Nature of Pigment Granules in the Cells of the Locus Coeruleus and Substantia Nigra
Foley, J. M., & Banter, D. (1958) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-195810000-00005 · Cited by 127
Enochs, W. S., Sarna, T., Zecca, L., Riley, P. A., & Swartz, H. M. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260963 · Cited by 123 · cited 1×
“Furthermore, if reactive oxygen species can degrade NM (Enochs et al. 1994; Swartz et al. 1992; Zareba et al. 1995), the pigment might lose its putatively protective role.”
BackgroundSelf-citationTyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease
Greggio, E., Bergantino, E., Carter, D., Ahmad, R., Costin, G., Hearing, V. J., Clarimon, J., Singleton, A., Eerola, J., Hellström, O., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03019.x · Cited by 121
Structural Characteristics of Human Substantia Nigra Neuromelanin and Synthetic Dopamine Melanins
Double, K. L., Zecca, L., Costi, P., Mauer, M., Griesinger, C., Ito, S., Ben‐Shachar, D., Bringmann, G., Fariello, R. G., Riederer, P., et al. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752583.x · Cited by 119 · cited 2×
“iron at two sites that differ for their binding strength, defined as high and low affinity sites (Double et al. 2003; Fasano et al. 2006; Zecca et al. 2008b). Most of the iron is Neurotox Res (2014) 25:13–23 15”
BackgroundMethodSelf-citationModifications of the iron–neuromelanin system in Parkinson's disease
Fasano, M., Bergamasco, B., & Lopiano, L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03638.x · Cited by 117
Liang, C., Nelson, O., Yazdani, U., Pasbakhsh, P., & German, D. C. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20098 · Cited by 117
Catecholamines oxidation by xanthine oxidase
Foppoli, C., Coccia, R., Cini, C., & Rosei, M. A. (1997) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(96)00093-1 · Cited by 117 · cited 1×
“Enzymatic oxidation of DA could also occur via prostaglandin H synthase or xanthine oxidase that leads to the formation of dopaminoquinone (Foppoli et al. 1997; Hastings 1995; Mattammal et al. 1995).”
BackgroundAutoradiography of [14C]paraquat or [14C]diquat in frogs and mice: Accumulation in neuromelanin
Lindquist, N. G., Larsson, B. S., & Lydén‐Sokolowski, A. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90002-x · Cited by 115
Pigmentation in the nucleus substantiae nigrae of mammals.
MARSDEN, C. D. (1961) · PubMed Central · Cited by 114
Preservation of hypothalamic dopaminergic neurons in Parkinson's disease
Matzuk, M. M., & Saper, C. B. (1985) · Annals of Neurology · doi:10.1002/ana.410180507 · Cited by 113
Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra
Gerlach, M., Trautwein, A. X., Zecca, L., Youdim, M. B. H., & Riederer, P. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020923.x · Cited by 113 · cited 1×
“2001b, 2004), as established by Mössbauer spectroscopy (Gerlach et al. 1995).”
Self-citationTawara, T., Fukushima, T., Hojo, N., Isobe, A., Shiwaku, K., Setogawa, T., & Yamane, Y. (1996) · Archives of Toxicology · doi:10.1007/s002040050316 · Cited by 112
Beach, T. G., Sue, L. I., Walker, D. G., Lue, L. F., Connor, D. J., Caviness, J. N., Sabbagh, M. N., & Adler, C. H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0250-5 · Cited by 111 · cited 1×
“Interestingly, in line with studies which reported an age-related loss of SN pigmented neurons, extraneuronal NM deposits were also observed in SN of healthy aged subjects in association with sustained microglial activation (Beach et al. 2007).”
ResultBohic, S., Murphy, K., Paulus, W., Cloetens, P., Salomé, M., Susini, J., & Double, K. (2008) · Analytical Chemistry · doi:10.1021/ac801817k · Cited by 109 · cited 1×
“Other metals likely to be sequestered into NM include aluminum, lead, manganese, mercury, cobalt, cadmium, and selenium (Bohic et al. 2008; Zecca et al. 1994, 2001a, 2008a).”
BackgroundStudies on neuromelanin: I. A melanin system in the human adult brainstem
Bazelon, M., Fenichel, G. M., & Randall, J. O. (1967) · Neurology · doi:10.1212/wnl.17.5.512 · Cited by 103 · cited 1×
“In humans, NM is mostly evident in the catecholaminergic nuclei of the human brainstem, SN, and locus coeruleus (Duffy and Tennyson 1965; Fenichel and Bazelon 1968; Foley and Baxter 1958; Graham 1979), but NM-containing neurons are ubiquitous in the brain having been described in several areas including medulla oblong…”
BackgroundInfluence of neuromelanin on oxidative pathways within the human substantia nigra
Double, K. L., Ben-Shachar, D., Youdim, M. B. H., Zecca, L., Riederer, P., & Gerlach, M. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00218-0 · Cited by 102
Self-citation“Subcellular Proteomics” of Neuromelanin Granules Isolated from the Human Brain
Tribl, F., Gerlach, M., Marcus, K., Asan, E., Tatschner, T., Arzberger, T., Meyer, H. E., Bringmann, G., & Riederer, P. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400117-mcp200 · Cited by 98
Muthane, U., Yasha, T. C., & Shankar, S. K. (1998) · Annals of Neurology · doi:10.1002/ana.410430304 · Cited by 97 · cited 1×
“variations in the number of pigmented neurons (Gibb and Lees 1991; Kubis et al. 2000; Muthane et al. 1998; Pakkenberg et al. 1991).”
BackgroundInteraction of Human Substantia Nigra Neuromelanin with Lipids and Peptides
Zecca, L., Costi, P., Mecacci, C., Ito, S., Terreni, M., & Sonnino, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741758.x · Cited by 95
Self-citationSPECTROSCOPIC STUDIES OF SUBSTANTIA NIGRA PIGMENT IN HUMAN SUBJECTS*
Woert, M. H. V., Prasad, K. N., & Borg, D. C. (1967) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1967.tb10304.x · Cited by 91
The structure of neuromelanin and its iron binding site studied by infrared spectroscopy
Bridelli, M. G., Tampellini, D., & Zecca, L. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01001-7 · Cited by 86 · cited 1×
“Although several synthetic NM have been prepared starting from the auto-oxidation of DA (in the presence of cysteine, proteins, and metals), structural and chemical differences from natural NM still remain (Bridelli et al. 1999; Double et al. 2000; Engelen et al. 2012; Ferrari et al. 2013; Zecca et al. 1996, 2000).”
MethodSelf-citationKarlsson, O., Berg, C., Brittebo, E. B., & Lindquist, N. G. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00508.x · Cited by 82
Engelen, M., Vanna, R., Bellei, C., Zucca, F. A., Wakamatsu, K., Monzani, E., Ito, S., Casella, L., & Zecca, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048490 · Cited by 77
Self-citationDoes tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra?
Ikemoto, K., Nagatsu, I., Ito, S., King, R. A., Nishimura, A., & Nagatsu, T. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00649-1 · Cited by 74
EPR investigations of the iron domain in neuromelanin
Aime, S., Bergamasco, B., Biglino, D., Digilio, G., Fasano, M., Giamello, E., & Lopiano, L. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00014-8 · Cited by 72
Modulation by neuromelanin of the availability and reactivity of metal ions
Swartz, H. M., Sarna, T., & Zecca, L. (1992) · Annals of Neurology · doi:10.1002/ana.410320712 · Cited by 72
Self-citationShamoto‐Nagai, M., Maruyama, W., Yi, H. L., Akao, Y., Tribl, F., Gerlach, M., Osawa, T., Riederer, P. F., & Naoi, M. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0410-5 · Cited by 71 · cited 1×
“has also been proposed that NM could have a direct prooxidant effect on mitochondria, releasing redox active iron thus promoting the production of reactive oxygen and nitrogen species (Shamoto-Nagai et al. 2006), although this effect has been demonstrated only on mitochondria isolated from SH-SY5Y cells.”
BackgroundEvidence for specific phases in the development of human neuromelanin
Halliday, G. M., Fedorow, H., Rickert, C. H., Gerlach, M., Riederer, P. F., & Double, K. L. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0449-y · Cited by 65
Dolichol is the major lipid component of human substantia nigra neuromelanin
Fedorow, H., Pickford, R., Hook, J. M., Double, K. L., Halliday, G. M., Gerlach, M., Riederer, P., & Garner, B. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02975.x · Cited by 64
Encapsulation of a reactive core in neuromelanin
Ito, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606879103 · Cited by 64
Studies on neuromelanin: II. Melanin in the brainstems of infants and children
Fenichel, G. M., & Bazelon, M. (1968) · Neurology · doi:10.1212/wnl.18.8.817 · Cited by 62
BARDEN, H. (1970) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-197004000-00005 · Cited by 61
Biosynthetic pathway to neuromelanin and its aging process
Wakamatsu, K., Murase, T., Zucca, F. A., Zecca, L., & Ito, S. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12014 · Cited by 58
Self-citationNeuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells
Shamoto‐Nagai, M., Maruyama, W., Akao, Y., Osawa, T., Tribl, F., Gerlach, M., Zucca, F. A., Zecca, L., Riederer, P. F., & Naoi, M. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0211-2 · Cited by 56 · cited 1×
“increase the accumulation of ubiquitinated and denatured proteins in the cytoplasm contributing to the vulnerability of dopaminergic neurons (Shamoto-Nagai et al. 2004).”
BackgroundSelf-citationMelanin affinity and its possible role in neurodegeneration
Karlsson, O., & Lindquist, N. G. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1062-5 · Cited by 55 · cited 1×
“despite an initial neuroprotective effect, could be a doubleedged sword, as NM may gradually release these compounds into the cytosol under certain circumstances (Karlsson and Lindquist 2013; Lindquist et al. 1987).”
BackgroundHuman neuromelanin an endogenous microglial activator for dopaminergic neuron death
Zhang, W. (2013) · Frontiers in Bioscience · doi:10.2741/e591 · Cited by 53
Enzymatic dopamine peroxidation in substantia nigra of human brain
Galzigna, L., Iuliis, A. D., & Zanatta, L. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00313-2 · Cited by 51
Long-term retention of neurotoxic ?-carbolines in brain neuromelanin
stergren, A. X. D., Annas, A., Skog, K. I., Lindquist, N. G., & Brittebo, E. B. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0080-0 · Cited by 49 · cited 1×
“Potentially neurotoxic compounds like b-carbolines (Östergren et al. 2004) and b-N-methylamino-L-alanine (Karlsson et al.”
BackgroundTribl, F., Arzberger, T., Riederer, P. F., & Gerlach, M. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_8 · Cited by 48
Neuromelanic pigment in substantia nigra neurons of rats and dogs
DeMattei, M., Levi, A. C., & Fariello, R. G. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90614-2 · Cited by 48 · cited 1×
“This pigment can be found not only in human brain, but also in neurons of animals such as monkeys, dogs, horses, rats, and frogs (Barden 1971; DeMattei et al. 1986; Kemali and Gioffré 1985; Marsden 1961).”
BackgroundNeuromelanin is an immune stimulator for dendritic cells in vitro
Oberländer, U., Pletinckx, K., Döhler, A., Müller, N., Lutz, M. B., Arzberger, T., Riederer, P., Gerlach, M., Koutsilieri, E., & Scheller, C. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-116 · Cited by 48
Neuromelanin synthesis in rat and human substantia nigra
Rabey, J. M., & Hefti, F. F. (1990) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02251241 · Cited by 46
Kropf, A. J., Bunker, B. A., Eisner, M., Moss, S. C., Zecca, L., Stroppolo, A., & Crippa, P. R. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77755-0 · Cited by 43 · cited 1×
“echol groups of the NM melanic component (Kropf et al. 1998), and is so stored in an inactive form that prevents Fenton’s reaction and ascorbate oxidation (Zecca et al.”
BackgroundSelf-citationl‐DOPA Is a Substrate for Tyrosine Hydroxylase
Haavik, J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041720.x · Cited by 42
Fellman, J. H. (1958) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.21.1.58 · Cited by 41 · cited 1×
“The involvement of monoamine oxidase in NM biosynthesis was also hypothesized (Fellman 1958; Van Woert et al. 1967).”
BackgroundNeuromelanin and its Possible Protective and Destructive Properties
LINDQUIST, N. G., LARSSON, B. S., & LYDÉN‐SOKOLOWSKI, A. (1987) · Pigment Cell Research · doi:10.1111/j.1600-0749.1987.tb00403.x · Cited by 41
Ferrari, E., Engelen, M., Monzani, E., Sturini, M., Girotto, S., Bubacco, L., Zecca, L., & Casella, L. (2012) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-012-0951-7 · Cited by 38
Self-citationCowen, D. (1986) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198605000-00001 · Cited by 35 · cited 1×
“In humans, NM is mostly evident in the catecholaminergic nuclei of the human brainstem, SN, and locus coeruleus (Duffy and Tennyson 1965; Fenichel and Bazelon 1968; Foley and Baxter 1958; Graham 1979), but NM-containing neurons are ubiquitous in the brain having been described in several areas including medulla oblong…”
BackgroundSalazar, M. M., Td, S., & Pn, P. (1978) · PubMed · Cited by 35
Ward, W. C., Guan, Z., Zucca, F. A., Fariello, R. G., Kordestani, R., Zecca, L., Raetz, C. R. H., & Simon, J. D. (2007) · Journal of Lipid Research · doi:10.1194/jlr.c700008-jlr200 · Cited by 33
Self-citationMyoglobin Modification by Enzyme‐Generated Dopamine Reactive Species
Nicolis, S., Zucchelli, M., Monzani, E., & Casella, L. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200801014 · Cited by 30
Self-citationThe role of peroxidase in neuromelanin synthesis: a review.
Okun, M. R. (1997) · PubMed · Cited by 29
Barden, H. (1971) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-197110000-00009 · Cited by 23 · cited 1×
“This pigment can be found not only in human brain, but also in neurons of animals such as monkeys, dogs, horses, rats, and frogs (Barden 1971; DeMattei et al. 1986; Kemali and Gioffré 1985; Marsden 1961).”
BackgroundKemali, M., & Gioffré, D. (1985) · PubMed Central · Cited by 19
Naoi, M., Yi, H. L., Maruyama, W., Inaba, K., Shamoto‐Nagai, M., Akao, Y., Gerlach, M., & Riederer, P. F. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.082 · Cited by 12
Neuromelanin inhibits CXCL10 expression in human astroglial cells
Tousi, N. S., Buck, D. J., Zecca, L., & Davis, R. L. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.042 · Cited by 11
Self-citationEffects of paraquat on mitochondria of rat skeletal muscle
Yamamoto, T., Anno, M., & SATO, T. A. (1987) · Comparative Biochemistry and Physiology Part C Comparative Pharmacology · doi:10.1016/0742-8413(87)90098-3 · Cited by 11
Cowen, D. (1986) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198605000-00002 · Cited by 11
Investigation of the lipid component of neuromelanin
Fedorow, H., Pickford, R., Kettle, E., Cartwright, M., Halliday, G. M., Gerlach, M., Riederer, P. F., Garner, B., & Double, K. L. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0451-4 · Cited by 10
Zecca, L., Tampellini, D., Costi, P., Rizzio, E., Giaveri, G., & Gallorini, M. (2001) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1023/a:1013251510671 · Cited by 8
Self-citationLangston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Research works printed but not linked: 2
- Crippa R, Wang QJ, Eisner M, Moss SC, Zecca L, Zschack P, Gog T (1996) Structure of human neuromelanin by X-ray diffraction: comparison with synthetics. Abstract. XVIth Internat Pigment Cell Conference, Anaheim. Pigment Cell Res S5:2
- Sarna T, Korytowsky W, Zareba M, Zecca L (1993) Structure and chemical reactivity of metal-ion complexes with neuromelanin. XVth International Pigment Cell Conference, London. Pigment Cell Res 6:287
Cited by
Oxidative stress and Parkinson’s disease
Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00091 · Cited by 878
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
“As the resulting material accumulates in the cytosol, it is transferred to autophagic vacuoles that fuse with lysosomes and other autophagic vacuoles, forming the NM-containing organelles (Zucca et al., 2014).”
InfluentialSelf-citationIron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 578
Solano, F. (2014) · New Journal of Science · doi:10.1155/2014/498276 · Cited by 565
“The function of neuromelanin in the human substantia nigra is a very interesting and intriguing issue, as other mammals have no neuromelanin in the brain [181].”
BackgroundParkinson’s Disease: Biomarkers, Treatment, and Risk Factors
Emamzadeh, F. N., & Surguchov, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00612 · Cited by 568
Metadata
- Authors
- Zucca, F. A., Basso, E., Cupaioli, F. A., Ferrari, E., Sulzer, D., Casella, L., & Zecca, L.
- Affiliations
- Institute of Biomedical Technologies (IT)
- Columbia University (US)
- University of Pavia (IT)
- Corresponding author
- Zecca, Luigi
- ORCID
- Venue
- Neurotoxicity Research
- Published
- 2013-10-24
- Volume
- 25
- Issue
- 1
- Pages
- 13-23
- ISSN
- 1029-8428 (ISSN-L)
- 1476-3524
- OpenAlex
- W2032587951
- Cited by
- 243
- References
- 125
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 15 · 2023: 15 · 2022: 24 · 2021: 25 · 2020: 27 · 2019: 21 · 2018: 22 · 2017: 17 · 2016: 23 · 2015: 10 · 2014: 8
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurotoxicity Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- neuromelanin, substantia nigra, Parkinson's disease, dopaminergic neurons, neurodegeneration, neuroprotection, neuroinflammation, redox-active metals, catecholamines, neurotoxins
- MeSH terms
- Humans, Melanins, Substantia Nigra, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.